Chemistry-based imaging will lead to advances in better understanding of disease and faster pathways to treatment. We, a group of biophysicists, chemists and biologists, work together for developing advanced imaging tools to highlight chemical processes for biomedical applications.
January 2025, we received the NBSRI acceleration grant to study the subcellular toxicity of nanoplastics.
February 2023, we received a two-year subaward of a NHLBI R01 grant for super-resolution imaging of mitophagy.Â
September 2022, NIGMS awarded us a supplement fund (3R35GM128837-05S1) for Nikon TIRF add-on.
September 2021, NINDS awarded us a supplement fund (3R01NS121077-01S1) for Molecular Devices SpectraMax i3x.